# Immunovant, Inc.: Form DEF 14A, filed Jun 26, 2024

- Company: [Immunovant, Inc.](/companies/imvt.md) (CIK 1764013)
- Form: DEF 14A
- Filed: 2024-06-26
- Accepted by EDGAR: Jun 26, 2024, 06:56 ET
- Period: 2024-08-12
- Accession: 0001764013-24-000114
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1764013/000176401324000114/imvt-20240331defproxy.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1764013/000176401324000114/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1764013/000176401324000114/imvt-20240331defproxy.htm

Filed Jun 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001764013-24-000114. Last ingested by Listed: Oct 30, 2026, 16:48 ET. No prices; not investment advice.